‘Robust immune responses’ found in Covid-19 vaccine clinical trials point to 2021 release

Your video will begin in 10
Skip ad (3)
Subscribe to our YouTube channel for free here:

Coronavirus vaccine clinical trials under way around the world are showing promise with “robust immune responses” produced in humans, and those encouraging results are holding up despite mutations being found as the Covid-19 pandemic continues. But how soon can we realistically expect the shots to be proven safe and effective and made widely available? The South China Morning Post’s Elaine Ly spoke with Dr Kylie Quinn, a Vice-Chancellor’s Research Fellow in the Translational Immunology and Nanotechnology Programme at RMIT in Melbourne, Australia. The award-winning scientist also coordinates the Women’s Initiative Programme at the Australia and New Zealand Society of Immunology.

Follow us on:
Website: https://scmp.com
Facebook: https://facebook.com/scmp
Twitter: https://twitter.com/scmpnews
Instagram: https://instagram.com/scmpnews
Linkedin: https://www.linkedin.com/company/south-china-morning-post/
No Category
Be the first to comment